{"id":"https://openalex.org/W2373559083","doi":null,"title":"Analyzed the treatment effect of advanced gastric cancer about S-1 and Capecitabine combined with oxaliplatin","display_name":"Analyzed the treatment effect of advanced gastric cancer about S-1 and Capecitabine combined with oxaliplatin","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2373559083","mag":"2373559083"},"language":"en","primary_location":{"id":"mag:2373559083","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-LNBJ201104025.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764623283","display_name":"Chinese Journal of Geriatric Care","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of Geriatric Care","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081686904","display_name":"Zen Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Zen Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5081686904"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.3211218,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-gastric-cancer","display_name":"advanced gastric cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/s-1","display_name":"S-1","score":0.7879999876022339},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9850000143051147},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":1.0},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.703000009059906},{"id":"https://openalex.org/keywords/postoperative-recurrence","display_name":"postoperative recurrence","score":0.7979999780654907},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.6830000281333923},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.7179999947547913},{"id":"https://openalex.org/keywords/chemotherapy-tolerability","display_name":"chemotherapy tolerability","score":0.5120000243186951}],"concepts":[{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.9800926446914673},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.9785431623458862},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9619165062904358},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6924129128456116},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5752494931221008},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5535571575164795},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4818224012851715},{"id":"https://openalex.org/C2777299880","wikidata":"https://www.wikidata.org/wiki/Q413370","display_name":"Tegafur","level":3,"score":0.4177086651325226},{"id":"https://openalex.org/C2777501473","wikidata":"https://www.wikidata.org/wiki/Q1796666","display_name":"Body surface area","level":2,"score":0.4169584810733795},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.20689642429351807}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2373559083","doi":null,"is_oa":false,"landing_page_url":"http://en.cnki.com.cn/Article_en/CJFDTOTAL-LNBJ201104025.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764623283","display_name":"Chinese Journal of Geriatric Care","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of Geriatric Care","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3031385742","https://openalex.org/W2354858798","https://openalex.org/W2352324258","https://openalex.org/W2378057732","https://openalex.org/W2380629092","https://openalex.org/W2351732685","https://openalex.org/W2348819229","https://openalex.org/W2388473513","https://openalex.org/W2369493354","https://openalex.org/W4407209036"],"abstract_inverted_index":{"Objective":[0],"Comparative":[1],"analysis":[2],"the":[3,69,85,89,94,101,124,138],"treatment":[4],"effect":[5],"of":[6,118],"postoperation":[7,24],"recurring":[8,25],"gastric":[9,26,135],"cancer":[10,27],"about":[11,42],"S1":[12],"and":[13,29,82,100,115,137],"Capecitabine":[14,61],"combined":[15,128],"with":[16,34,54,79,129],"Oxaliplatin.":[17],"Methods":[18],"The":[19],"26":[20],"patients":[21,90],"which":[22],"were":[23,73,121,141],"received":[28],"cured.Observed":[30],"group":[31,51,120],"(12":[32],"cases)cured":[33,53],"Oxaliplatin":[35,55,130],"30":[36,56],"mg/m2,D1,":[37],"intravenous":[38,59],"drip,S-1":[39],"selected":[40],"40mg\uff5e60mg/times":[41],"body":[43],"surface":[44],"area,":[45],"2":[46,64],"times/d,":[47,65],"oral":[48,66],"administration,":[49,67],"D1~D14.Matched":[50],"(14":[52],"mg/m2,":[57],"D1,":[58],"drip;":[60],"applied":[62],"1500mg/times,":[63],"D1~D14.Both":[68],"methods":[70],"remedy":[71],"cycles":[72],"21":[74],"days.Effected":[75],"assessment":[76],"one":[77],"times":[78],"two":[80],"cycles,":[81],"follow-up":[83],"visited":[84],"patients'":[86],"condition.Results":[87],"All":[88],"can":[91],"be":[92],"evaluated,":[93],"observed":[95,119],"group's":[96,103],"RR":[97,104],"was":[98,105,131],"50%":[99],"matched":[102,125],"42.8%,":[106],"they":[107],"had":[108],"no":[109],"significant":[110],"differences,":[111],"but":[112],"adverse":[113,139],"effects":[114,140],"serious":[116],"reactions":[117],"clearly":[122],"under":[123],"group.Conclusion":[126],"S-1":[127],"effective":[132],"on":[133],"advanced":[134],"cancer,":[136],"tolerable.":[142]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}